Advanced search×

Effects of cytochrome P450 inducers and inhibitors on the pharmacokinetics of intravenous furosemide in rats: involvement of CYP2C11, 2E1, 3A1 and 3A2 in furosemide metabolism.

J Pharm Pharmacol 61(1):47-54 (2009) PMID 19126296

It has been reported that the non-renal clearance of furosemide was significantly faster in rats pretreated with phenobarbital but was not altered in rats pretreated with 3-methylcholanthrene. However, no studies on other cytochrome P450 (CYP) isozymes have yet been reported in rats.

DOI: 10.1211/jpp/61.01.0007
Version: za2963e q8zaa q8zbc q8zc4 q8zd5 q8zeb q8zf3 q8zg8

Similar articles you may find interesting…

  1. Factors associated with reduced efficacy of sitagliptin therapy: analysis of 93 patients with type 2 diabetes treated for 1.5 years or longe...

    J Clin Med Res 5(3):217-21 (2013) PMID 23671547

    Several studies have shown the effectiveness of sitagliptin, a dipeptidyl peptidase-4 inhibitor, for type 2 diabetes, with a hypoglycemic effect being demonstrated both when it is administered alone or in combination with other oral antidiabetic agents. However, there are few reports...
  2. [Allergen immunotherapy for allergic rhinitis.]

    Rhinology 51(2):99-110 (2013) PMID 23671890

    Allergic rhinitis, a risk factor for bronchial asthma, is a global health problem that impairs patients` physical and social activity and consequently their quality of life. Specific Immunotherapy (SIT) involves the administration, subcutaneously or sublin- gually, of increasing dose...
  3. Dynamic Modeling of Cytochrome P450 Inhibition In Vitro: Impact of Inhibitor Depletion on IC50-shift.

    Drug Metab Dispos (2013) PMID 23649703

    The impact of inhibitor depletion on the determination of shifted IC50 (IC50 determined after 30 minute preincubation with inhibitor) is examined. In addition, IC50 shift data are analyzed using a mechanistic model that incorporates the processes of inhibitor depletion, as well as, r...